(Q44381630)

2 December 2017

title

Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients (English)

1 reference

2 December 2017

Tamar L Gur

5

0 references

John Q. Trojanowski

7

object named as

John Q Trojanowski

1 reference

2 December 2017

Mei-Ping Kung

1

1 reference

2 December 2017

Daniel M Skovronsky

2

1 reference

2 December 2017

Catherine Hou

3

1 reference

2 December 2017

Zhi-Ping Zhuang

4

1 reference

2 December 2017

Bin Zhang

6

1 reference

2 December 2017

Virginia M-Y Lee

8

1 reference

2 December 2017

Hank F Kung

9

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Journal of Molecular Neuroscience

2 December 2017

published in

1 reference

2 December 2017

volume

20

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

15-24

1 reference

https://scigraph.springernature.com/pub.10.1385/jmn:20:1:15

2 December 2017

exact match

0 references

cites work

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

Imaging Alzheimer's amyloid

1 reference

12 December 2020

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

12 December 2020

IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain

1 reference

12 December 2020

Targeting alzheimer amyloid plaques in vivo

1 reference

12 December 2020

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain

1 reference

12 December 2020

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.

1 reference

12 December 2020

Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease

1 reference

12 December 2020

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

12 December 2020

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

1 reference

12 December 2020

Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides

1 reference

12 December 2020

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

12 December 2020

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

12 December 2020

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

1 reference

12 December 2020

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

1 reference

12 December 2020

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

12 December 2020

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

1 reference

12 December 2020

Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections.

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:20:1:15

1 reference

Dimensions Publication ID

2 December 2017

1052274456

0 references

1 reference